The prevalence of neurological diseases is currently growing due to the combination of several factor, including poor lifestyle and environmental imbalance which enhance the contribution of genetic factors. Parkinson's disease (PD), a chronic and progressive neurological condition, is one of the most prevalent neurodegenerative human diseases. Development of models may help to understand its pathophysiology. This review focuses on studies using invertebrate models to investigate certain chemicals that generate parkinsonian-like symptoms models. Additionally, we report some preliminary results of our own research on a crustacean (the crab Ucides cordatus) and a solitary ascidian (Styela plicata), used after induction of parkinsonism with 6-hydroxydopamine and the pesticide rotenone, respectively. We also discuss the advantages, limits, and drawbacks of using invertebrate models to study PD. We suggest prospects and directions for future investigations of PD, based on invertebrate models.

Parkinson's disease (PD) is a chronic, progressive, and neurodegenerative condition that has been increasing faster than any other neurological disorder in age-standardized rates of prevalence, disability, and deaths [1–4]. Approximately 8.5 million individuals have PD worldwide, with an estimated 81% increase in the number of individuals affected by PD since 2000 [5]. Additionally, the global prevalence of PD increased ∼155% from 1990 to 2019 [6].

While the etiology of PD is still largely unknown, the condition is multifactorial, with genetic and sporadic (idiopathic) cases contributing to the disease genesis [7]. Genetic cases follow Mendelian inheritance in an autosomal dominant or recessive manner; ∼90% of cases are sporadic, in which the exact pathogenic mechanisms are not completely understood [8]. Although only 10% of PD cases involve known genetic mutations, Giambò et al. [9] proposed that environmental factors largely contribute to the prevalence of this disease, and in fact found that the association between pesticides and exposure to high levels of heavy metals increased the risk of development of sporadic PD [9]. The proposed mechanism was the modulation of the expression levels of different PD (PARK) genes and DNA methylation. Certain environmental factors associated with a rural lifestyle (drinking well water and exposure to pesticides) have been identified as possible risk factors for PD [10].

PD pathogenesis consists of a progressive loss of dopaminergic neurons in the substantia nigra pars compacta, involving misfolding and abnormal aggregation of α-synuclein, mitochondrial abnormalities in the neurons, neuroinflammation, and oxidative stress [11–14]. Environmental pesticides, such as paraquat and rotenone, and other chemicals, such as 6-hydroxydopamine (6-OHDA) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), have been used to generate animal models to help reveal PD pathogenesis [15–17]. However, although the use of these models has generated new knowledge in this field, an effective treatment or cure for the disease has yet to be found [18,19].

Because of ethical issues regarding the use of vertebrate animals, invertebrates have emerged as models. Although less frequently used to study PD, invertebrates offer several advantages, such as short lifespans, ease of maintenance and manipulation, low cost, and genetic homology to vertebrates [20,21]. Additionally, this group of animals concords with the principles of human experimental techniques based on the 3 R's (replacement, reduction, and refinement) coined by Russel and Burch [22], promoting the use of animals for human treatment purposes. Therefore, chemicals used in mammal models have been applied in invertebrates to study cause-effect, disclose pathogenic mechanisms, screen drug treatments, reveal the function of genes, and induce parkinsonian signs [23–25].

In this review, we discuss recent advancements in the use of invertebrates as models to study parkinsonism after the disease was induced with certain chemicals, particularly 6-OHDA, MPTP, rotenone, and paraquat. Investigation of the effects of pesticides on invertebrates provide valuable information, not only because these animals are useful models, but also because they respond to (and therefore may be used as bioindicators) and are impacted by environmental toxic agents. We focus on some of the invertebrate models that have been studied: flatworms and nematodes, mollusks, arthropods, and solitary ascidians, and describe some of our preliminary results using the crab Ucides cordatus and the ascidian Styela plicata. We review some data published in the articles that illustrate how invertebrate models may help to understand the pathophysiology of PD. We also discuss the implications of these studies for humans, stressing the advantages of using them with a special focus on neuroprotection.

Planarians have an almost unlimited capacity to regenerate tissues. This phenomenon has long fascinated naturalists; in the Western Hemisphere alone, their documented history spans more than 200 years. Pieces of planarians can regenerate into a complete organism, including the cephalic ganglion, their ‘brain’, as reviewed by Elliott and Alvarado [26]. Some decades ago, the damage to dopaminergic cells in planarians following exposure to 6-OHDA [27], MPTP, or rotenone [28] was evidenced. These studies indirectly revealed that dopaminergic cells and dopaminergic receptors occur in planarians. In 2007, Nishimura et al. [29] identified genes that code their dopamine biosynthetic enzymes. Additionally, neurochemical and histochemical data indicated the presence of several neurotransmitter-receptor systems, showing that planarians may contribute significantly to knowledge of neuropharmacology, including the dopaminergic system [30].

In 2011, Nishimura et al. [31] examined cellular aspects of dopaminergic neurogenesis/regeneration from stem cells after selective degeneration of dopaminergic neurons by 6-OHDA. These observations suggest that planarians are suitable animal models for analyzing the system that recognizes the ablation of dopaminergic signals and the system for recruitment of new dopaminergic neurons. Interestingly, based on the cell responses to their environment and on how dopaminergic neurons are recruited after neurodegeneration, the study by Nishimura's group suggests some approaches that can lead to treatments of neurodegenerative diseases such as PD.

The nematode Caenorhabditis elegans is ∼1 mm long, free-living, with a short life span (∼3 weeks) and a transparent body wall that allows visualization of all cell types at all stages of development [32]. Its nervous system has 302 neurons [33], including eight dopaminergic neurons in the hermaphrodite form [34,35].

Because these worms can be engineered to express human proteins associated with neurodegeneration, they have been considered appropriate to study PD. PD is characterized by the progressive loss of dopaminergic neurons and accumulation of protein inclusions, mainly of α-synuclein, known as Lewy bodies (LB). Since LB can be considered a histological hallmark of PD, many studies have used C. elegans transgenic models to reveal the mechanisms and effects of α-synuclein [20,36,37]. Transgenic C. elegans co-expressing α-synuclein and green fluorescence protein (GFP) in dopaminergic neurons were associated with neurodegeneration [36]. This approach has been particularly useful as a model of α-synuclein-mediated neurodegeneration to validate molecular or chemical modulators of α-synuclein discovered in yeast [38,39]. Hardenberg et al. [40] recently reported that a C. elegans model of PD helped to understand the relationship between α-synuclein self-assembly and the LB formation. These authors proposed that the formation of LB is associated with the blocked maturation of α-synuclein condensates in the presence of lipids and possibly other intracellular substances, as also reviewed by [41].

In addition to genetic studies, C. elegans has been used to study the effects of pesticides and neurotoxins [42]. Braungart et al. [43] reported that PD-like symptoms can be generated in C. elegans by incubating the animals with the neurotoxic agent 1-methyl-4-phenylpyridinium (MPP+), a metabolite of MPTP. Exposure to MPP+ resulted in the death of dopaminergic neurons, reduced mobility, and increased mortality. Masoudi et al. [44] reported that the neurotoxin 6-OHDA generated locomotion defects, tested by a paralysis assay, and loss of dopaminergic neurons fused to GFP. The same study showed that 6-OHDA altered the function of the dopamine active transporter (DAT). Also, Jadiya et al. [37] reported that treatment with 1 mM paraquat modified the expression of heat shock proteins (hsp). Particularly, hsp70 was reduced, possibly affecting cell death, and hsp60 was increased, confirming that paraquat caused oxidative stress. A dose of 4 µM of rotenone impaired the growth of C. elegans, caused the loss of dopaminergic neurons, and blocked mitochondrial DNA replication as reported by Zhou et al. [45]

Recently, Sohrabi et al. [46] linked the dysfunction of the branched-chain amino acid transferase 1 (BCAT1) to PD, and reported that RNAi-mediated knockdown of neuronal BCAT1 in C. elegans causes abnormal spasm-like ‘curling’ behavior with age. In a proof-of-concept screen of 50 FDA-approved drugs, the same study identified at least four candidates for potential late-in-life intervention in PD: enasidenib, ethosuximide, metformin, and nitisinone. These findings indicate the utility of the proposed high-throughput platform for automated scoring of worm postures, and in particular, the discovery of potential candidate treatments for PD.

The snail Lymnaea stagnalis is a freely moving aquatic mollusk that shows relatively simple behaviors — locomotion, respiration, and feeding — that can be easily quantified and analyzed on a cellular level [47]. One of the most-studied interneurons in the Lymnaea central nervous system (CNS) is the dopaminergic giant pedal neuron RPeD1, which is involved in locomotor coordination [48]. Vehovszky et al. [49] reported that rotenone disrupts feeding and locomotion in this snail, and because one possible target of rotenone is the dopaminergic neurons in the CNS, suggested that L. stagnalis is a suitable invertebrate model for the study of PD. These authors claimed that the model allows direct analysis of the response of dopaminergic systems to rotenone at the behavioral (reduction in spontaneous locomotion and decreased feeding frequency), cellular [reduction in tyrosine hydroxylase (TH) and dopamine intracellular proportions], and neuronal levels (impairment of dopaminergic inputs of RPeD1).

Dopaminergic neurons, in both vertebrates and invertebrates, have high oxygen consumption and metabolic rates, and generate large quantities of reactive oxygen species (ROS) that can damage mitochondria. Oxidative stress and mitochondrial dysfunction play key roles in the selective destruction of dopaminergic neurons [50,51]. In an ecological approach, Ferreira et al. [52] analyzed the effect of organochlorine pesticides on the oyster Crassostrea gasar. Since the study showed protective mechanisms triggered by ROS (including the production of the enzymes superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase, and glucose-6-phosphate dehydrogenase) [53], oysters also proved to be useful to monitor aquatic biosystems.

Crustaceans

The decapod Palaemonetes argentinus is a small South American freshwater shrimp that has been used as an indicator of sites with low environmental quality. Bertrand et al. [54] showed oxidative stress in this shrimp obtained from ecosystems impacted by organic and inorganic pollutants. Since paraquat releases transition metal from storage metalloproteins [55] and triggers the degeneration of dopaminergic neurons in rats [17], P. argentinus impacted by pollutants proved to be useful bioindicators in aquatic ecosystems [54]. Behavioral studies have also provided tools to study effects of different chemicals on motor responses in crustaceans [56,57]. However, more-direct studies using these models should be conducted in order to monitor for pesticides.

Using the crayfish Pacifastacus as a PD model, Davison et al. [58] reported that the electrophysiological properties of the axons were altered. 6-OHDA (20 mM) affected the axonal permeability, with decreased spike amplitude and enhanced rise time duration. In contrast, the treatment with CAT and SOD promoted axonal protection. In order to understand the effects of 6-OHDA in another invertebrate model, the mangrove crab U. cordatus, we conducted an in vitro study. Following the protocol described in [59], we used cell cultures from the cerebral ganglia of this crab and observed the reduction in the number of TH+ cells in all experimental groups, 1, 3, and 5 days after the exposure to 6-OHDA. During the experimental period, we observed a decrease in the number of TH+ cells in the treatment groups compared with each other (a progressive reduction) and with the controls (Figure 1).

Quantification of tyrosine hydroxylase (TH)+ cells in control and experimental groups (treated with 100 µM of 6-hydroxydopamine, 6-OHDA).

Figure 1.
Quantification of tyrosine hydroxylase (TH)+ cells in control and experimental groups (treated with 100 µM of 6-hydroxydopamine, 6-OHDA).

(A) comparison of control with experimental groups (1, 3, and 5 days of exposure to 6-OHDA). The results showed reduction in TH+ cells in all experimental groups compared with the controls. (B) comparison of treated groups with each other revealed decreases in TH+ cells during the course of the experiment.

Figure 1.
Quantification of tyrosine hydroxylase (TH)+ cells in control and experimental groups (treated with 100 µM of 6-hydroxydopamine, 6-OHDA).

(A) comparison of control with experimental groups (1, 3, and 5 days of exposure to 6-OHDA). The results showed reduction in TH+ cells in all experimental groups compared with the controls. (B) comparison of treated groups with each other revealed decreases in TH+ cells during the course of the experiment.

Close modal

Drosophila

Compared with planarians and C. elegans, Drosophila melanogaster has a more-developed nervous system, including ∼300 dopaminergic neurons [60]. D. melanogaster has emerged as an excellent model organism to study both environmental and genetic factors, providing information on pathways relevant for the PD pathogenesis [61]. Analyses of the functions and mechanisms of the genetic factors associated with PD — such as the encoding α-synuclein for PARK1 [62], PARK4 [63], LRRK2 (PARK8) [64], VPS35 (PARK17) [65], and SYANJ1 (PARK20) [66], and the environmental factors, consisting of oxidative stress-induced toxins, such as MPTP, paraquat, and rotenone [67] — have provided important insights into the disease process. One important conclusion was that these factors cause oxidative damage and mitochondrial dysfunction.

The Drosophila model has been also valuable to help to develop new therapeutic strategies. Recent studies have described the neuroprotective effect of ginsenosides, such as Ginsenoside Re [68–70]. The neuroprotective effects of Ginsenoside Re, one of the most active ingredients in ginseng, on a rotenone-induced model of PD, the Drosophila brain, were shown and considered the most potent inhibitor of rotenone-induced cytotoxicity [71]. The neuroprotective effects of Ginsenoside Re reduced the rotenone-induced loss of TH+ neurons and partially restored the defects in motor behavior of the Drosophila flies. Additionally, the results in [71] suggest that Ginsenoside Re strengthens the cellular antioxidant response by increasing SOD, GPx, and glutathione expression, and reducing the malondialdehyde content.

Another compound tested in Drosophila was the poly-methoxyflavonoid, GardeninA. It was shown to have a neuroprotective potential against paraquat-induced parkinsonian symptoms involving reduced survival, mobility defects, and loss of dopaminergic neurons. In addition to being dependent on its antioxidant activities, GardeninA-mediated neuroprotection also involves modulation of the neuroinflammatory and cellular death responses [72].

Ascidians are marine invertebrates that are considered the closest relatives to vertebrates [73]. Dopaminergic neurons have been located in the CNS of larvae of the solitary ascidian Phallusia mammillata, in cells related to the otolith, and they have been described as modulators of the onset of metamorphosis in larvae of this species [74]. In another solitary ascidian, Ciona intestinalis, transcripts of TH were found in some cells of the left portion of the sensory vesicle of tadpole larvae [75].

Ascidians have been considered appropriate models for studies on factors that protect from toxic effects of pesticides, which can trigger the onset of PD. Zega et al. [76] studied the toxicity of paraquat to P. mammillata larvae and compared it to vertebrate organisms. They observed a decrease in dopamine content in the CNS of treated larvae; however, in combined treatments with paraquat and l-ascorbic acid, a common antioxidant, the severity of the malformations was significantly reduced [76]. This result suggests that the oxidative stress is involved in the mechanism of paraquat toxicity to ascidians, similarly to previous descriptions in vertebrates, as recently reviewed by [77].

In the adult, dopaminergic neurons have not been described. However, a molecular study by our group showed that dopaminergic receptors are present in the adult ascidian Phallusia nigra [78]. Currently, we are investigating potential effects of rotenone, using adults of another ascidian, S. plicata. We conducted a motor behavioral test to analyze the time that ascidians take to close their siphons [79,80]. We injected the animals systemically with 3.0 mg/Kg rotenone, and then stimulated one siphon mechanically from the day of injection until the 10th day, in order to test the time to closure of both siphons. Preliminary results revealed that ascidians took longer to close their siphons two days after the injection of rotenone, compared with day 0, and continued to take longer until the seventh day after rotenone injection. The time to closure of the siphons returned to control levels at the 10th day (Figure 2). To our knowledge, this test has not been used before in PD models, and this is the first study to associate ascidians to parkinsonism using a motor behavior test.

Effect of rotenone on the ascidian Styela plicata as evaluated by the siphon test.

Figure 2.
Effect of rotenone on the ascidian Styela plicata as evaluated by the siphon test.

After systemic injection with 3 mg/kg of rotenone, the time of closure of the oral siphon after mechanical stimulation was evaluated from days 0 to 10 after injection. (*) animals injected with rotenone versus control animals; (•) control animals; (▪) animals injected only with dimethyl sulfoxide (DMSO), the vehicle used to solubilize the rotenone; (Δ) animals injected with 3 mg/kg rotenone. * P < 0.05, *** P < 0.001, **** P < 0.0001. (#) rotenone-injected animals versus DMSO-injected animals, ## P < 0.01, #### P < 0.0001.

Figure 2.
Effect of rotenone on the ascidian Styela plicata as evaluated by the siphon test.

After systemic injection with 3 mg/kg of rotenone, the time of closure of the oral siphon after mechanical stimulation was evaluated from days 0 to 10 after injection. (*) animals injected with rotenone versus control animals; (•) control animals; (▪) animals injected only with dimethyl sulfoxide (DMSO), the vehicle used to solubilize the rotenone; (Δ) animals injected with 3 mg/kg rotenone. * P < 0.05, *** P < 0.001, **** P < 0.0001. (#) rotenone-injected animals versus DMSO-injected animals, ## P < 0.01, #### P < 0.0001.

Close modal

Table 1 summarizes reports that used invertebrates as models for PD studies. In this mini-review we focused on some ongoing research using invertebrate models that may provide clues to understand mechanisms of PD, environmental causes, such as those generated by pesticides or chemical use, and certain current therapeutic approaches.

Table 1
Use of invertebrates to model chemically induced parkinsonism-symptoms
Animal modelChemical usedStudy approach
Flatworms 6-OHDA Immunostaining (with DjTH and AADCA antibodies); Behavioral analysis (negative phototaxis assay); HPLC (quantitative analysis of DA) [31
Nematodes MPP+
6-OHDA
Rotenone
Paraquat 
Locomotion tests (MPP+ decreased the locomotion in a dose-dependent manner); MPP+ affected genetic expression of dopaminergic GFP+ neurons [43]
Paralysis assay; Loss of dopaminergic GFP+ neurons; Alteration of DAT function [44]
Microscopic analysis (growth impairment and loss of dopaminergic neurons labeled with GPF).
qPCR (blocked mitochondrial DNA replication) [45]
qPCR (modified the expression of hsp-70 and hsp-60) [37
Mollusks Rotenone Behavioral tests (locomotion assay and feeding behavior); Electrophysiological experiments (to determine intracellular activity of dopaminergic neurons from pedal ganglia);
HPLC (quantify dopamine); Immunocytochemistry (TH and dopamine) [49
Crustaceans 6-OHDA Electrophysiological tests of the nerve cord (6-OHDA reduced spike amplitude, increased axonal permeability, and enhanced rise time and duration of action potential); The enzymes SOD and catalase restored neuronal excitability [58
Drosophila Rotenone, Paraquat, Ginsenoside Re (neuroprotective effects) Longevity and survival tests; Locomotion activity (climb); Biochemical parameters (total protein determination); Analysis of toxicity [catalase, hydrogen-peroxide level, nitric-oxide (nitrate/nitrite) level]; Acetylcholinesterase activity; Malondialdehyde level; Protein carbonyl content; Cell viability (mitochondrial metabolic rate); Molecular docking [81]
Mobility assay; Immunofluorescence analysis (and GFP-positive dopaminergic neurons); Quantitative real-time RT-PCR (expression of Relish, the human NFκB orthologue); Nitric-oxide analysis; Lipid-peroxidation assay; UPLC-QTOF-MS SIR analysis of Drosophila head extracts; Caspase-3 activity [72]
Cell viability (MTT based); Cell apoptosis (Annexin V); Nitrite concentration;TNF-α and IL-6 concentrations; ROS levels (CM-H2DCFDA); Western-blot analysis [68]
Behavioral tests (climb setup, flying tests, gait analysis) [82
Ascidians Paraquat Morphological analysis of Phallusia mammillata larvae;Immunohistochemistry of β-tubulin, dopamine, and GABA; In situ hybridization (expression of TH) [76
Animal modelChemical usedStudy approach
Flatworms 6-OHDA Immunostaining (with DjTH and AADCA antibodies); Behavioral analysis (negative phototaxis assay); HPLC (quantitative analysis of DA) [31
Nematodes MPP+
6-OHDA
Rotenone
Paraquat 
Locomotion tests (MPP+ decreased the locomotion in a dose-dependent manner); MPP+ affected genetic expression of dopaminergic GFP+ neurons [43]
Paralysis assay; Loss of dopaminergic GFP+ neurons; Alteration of DAT function [44]
Microscopic analysis (growth impairment and loss of dopaminergic neurons labeled with GPF).
qPCR (blocked mitochondrial DNA replication) [45]
qPCR (modified the expression of hsp-70 and hsp-60) [37
Mollusks Rotenone Behavioral tests (locomotion assay and feeding behavior); Electrophysiological experiments (to determine intracellular activity of dopaminergic neurons from pedal ganglia);
HPLC (quantify dopamine); Immunocytochemistry (TH and dopamine) [49
Crustaceans 6-OHDA Electrophysiological tests of the nerve cord (6-OHDA reduced spike amplitude, increased axonal permeability, and enhanced rise time and duration of action potential); The enzymes SOD and catalase restored neuronal excitability [58
Drosophila Rotenone, Paraquat, Ginsenoside Re (neuroprotective effects) Longevity and survival tests; Locomotion activity (climb); Biochemical parameters (total protein determination); Analysis of toxicity [catalase, hydrogen-peroxide level, nitric-oxide (nitrate/nitrite) level]; Acetylcholinesterase activity; Malondialdehyde level; Protein carbonyl content; Cell viability (mitochondrial metabolic rate); Molecular docking [81]
Mobility assay; Immunofluorescence analysis (and GFP-positive dopaminergic neurons); Quantitative real-time RT-PCR (expression of Relish, the human NFκB orthologue); Nitric-oxide analysis; Lipid-peroxidation assay; UPLC-QTOF-MS SIR analysis of Drosophila head extracts; Caspase-3 activity [72]
Cell viability (MTT based); Cell apoptosis (Annexin V); Nitrite concentration;TNF-α and IL-6 concentrations; ROS levels (CM-H2DCFDA); Western-blot analysis [68]
Behavioral tests (climb setup, flying tests, gait analysis) [82
Ascidians Paraquat Morphological analysis of Phallusia mammillata larvae;Immunohistochemistry of β-tubulin, dopamine, and GABA; In situ hybridization (expression of TH) [76

AADCA, Aromatic Amino Acid Decarboxylase; CM-H2DCFDA, General Oxidative Stress Indicator; DA, Dopamine; DAT, Dopamine Active Transporter; DjTH, Dugesia. japonica Tyrosine Hydroxylase; GABA, Gamma Aminobutyric Acid; GFP, Green Fluorescent Protein; HPLC, High Performance Liquid Chromatography; hsp, Heat-Shock Proteins; IL-6, Interleukin-6; MPP+, 1-methyl-4-phenylpyridinium; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide; NFκB, Nuclear Factor Kappa B; NO, Nitric Oxide; qPCR, Quantitative Polymerase Chain Reaction; RT-PCR, Real-time Polymerase Chain Reaction; ROS, Reactive Oxygen Species; SOD, Superoxide Dismutase; TH, Tyrosine Hydroxylase; TNF-α, Tumor Necrosis Factor-α; UPLC-QTOF-MS SIR, Ultra-performance Liquid Chromatography Quadrupole Time-of-flight Mass Spectrometry Selected Ion Recording; 6-OHDA, 6-hydroxydopamine.

Invertebrates used as animal models for neurodegenerative diseases, such as PD, enable a better understanding of fundamental biological mechanisms. Certain invertebrates (C. elegans and Drosophila) have demonstrated a high degree of gene and intracellular-pathway homologies with humans and may serve as models for developing novel therapeutic approaches. Invertebrates have both advantages and limits/drawbacks as animal models for diseases, including but not limited to PD (Figure 3). Readers must keep in mind that it is not possible to model all diseases using invertebrates, because they do not have all corresponding human genes and similar organs to humans. Another drawback is the body constitution of invertebrates, since some have cuticles that act as a physical barrier, limiting pharmacokinetic approaches (absorption, distribution, and metabolism) to using them as models for investigating human diseases.

Groups of invertebrates used as models to study parkinsonism.

Figure 3.
Groups of invertebrates used as models to study parkinsonism.
Figure 3.
Groups of invertebrates used as models to study parkinsonism.
Close modal

Invertebrates and vertebrates share some molecules, although certain molecules may not be involved in the same functions. Dopamine is the key molecule for responses, such as food reward and motor functions in many animal groups. One exception is the arthropods, in which the molecule related to reward is the biogenic amine octopamine [97]. Therefore, focusing on different invertebrate models may help to understand, from an evolutionary point of view, the role of key molecules in different neurological human diseases such as PD.

While mammals, including humans, are not capable of regenerating their CNS after mechanical, chemical, or pathological damage such as occurs in neurological diseases, invertebrates have a considerable ability to restore their nervous system [26,80,96,98]. Neuroregeneration mechanisms are under investigation, and the increase in knowledge of the mechanisms underlying this process may help to understand the roles of cells, molecules and genes, which could be used to develop molecular targets to treat PD in the future.

  • Currently, invertebrate models are being used to understand the pathophysiology of PD. This research may have implications for humans and suggest directions of future studies.

  • Less frequently used to study PD, invertebrates as a group have several advantages, such as short lifespans, ease of maintenance and manipulation, low cost, and genetic homology with vertebrates.

  • Because invertebrates have several advantages, invertebrate models can provide clues to develop new therapeutic targets for PD.

The authors declare that there are no competing interests associated with the manuscript.

This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior — Brasil (CAPES) — Finance Code 001 to N.S.N., by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq/Brazil) to C.A.B.A.G., T.B.M. and S.A., and by the Fundação Carlos Chagas Filho de Apoio à Pesquisa do Estado do Rio de Janeiro (FAPERJ) to C.L.C., A.A.M., C.M.B. and S.A. Janet W. Reid (JWR Associates, New York, U.S.A.) revised the English.

6-OHDA

6-hydroxydopamine

BCAT1

branched-chain amino acid transferase 1

CAT

catalase

CNS

central nervous system

DAT

dopamine active transporter

GFP

green fluorescent protein

GPx

glutathione peroxidase

hsp

heat shock proteins

LB

Lewy bodies

MPP+

1-methyl-4-phenylpyridinium

MPTP

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

PARK

PD genes

PD

Parkinson's disease

ROS

reactive oxygen species

RPeD1

dopaminergic giant pedal neuron

SOD

superoxide dismutase

TH

tyrosine hydroxylase

1
Savica
,
R.
,
Grossardt
,
B.R.
,
Bower
,
J.H.
,
Ahlskog
,
J.E.
,
Boeve
,
B.F.
,
Graff-Radford
,
J.
et al (
2017
)
Survival and causes of death among people with clinically diagnosed synucleinopathies with parkinsonism: a population-based study
.
JAMA Neurol.
74
,
839
846
2
Rossi
,
A.
,
Berger
,
K.
,
Chen
,
H.
,
Leslie
,
D.
,
Mailman
,
R.B.
and
Huang
,
X.
(
2017
)
Projection of the prevalence of Parkinson's disease in the coming decades: revisited
.
Mov. Disord.
33
,
156
159
3
Darweesh
,
S.K.L.
,
Raphael
,
K.G.
,
Brundin
,
P.
,
Matthews
,
H.
,
Wyse
,
R.K.
,
Chen
,
H.
et al (
2018
)
Parkinson matters
.
J. Parkinson's Dis.
8
,
495
498
4
GBD 2016 Parkinson's Disease Collaborators
. (
2018
)
Global, regional, and national burden of Parkinson's disease in 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
.
Lancet Neurol.
17
,
939
953
6
Ou
,
Z.
,
Pan
,
J.
,
Tang
,
S.
,
Duan
,
D.
,
Yu
,
D.
,
Nong
,
H.
et al (
2021
)
Global trends in the incidence, prevalence, and years lived with disability of Parkinson's disease in 204 countries/territories from 1990 to 2019
.
Front. Public Health
9
,
1
16
7
Surguchov
,
A.
(
2022
) Biomarkers in Parkinson's Disease. In
Neurodegenerative Diseases Biomarkers. Neuromethods
(
Peplow
,
P.V.
,
Martinez
,
B.
,
Gennarelli
,
T.A.
, eds), vol.
173
, pp.
155
180
,
Humana
,
New York, NY
8
Kluss
,
J.H.
,
Mamais
,
A.
and
Cookson
,
M.R.
(
2019
)
LRRK2 links genetic and sporadic Parkinson's disease
.
Biochem. Soc. Trans.
47
,
651
661
9
Giambò
,
F.
,
Leone
,
G.M.
,
Gattuso
,
G.
,
Rizzo
,
R.
,
Cosentino
,
A.
,
Cinà
,
D.
et al (
2021
)
Genetic and epigenetic alterations induced by pesticide exposure: integrated analysis of gene expression, microRNA expression, and DNA methylation datasets
.
Int. J. Environ. Res. Public Health
18
,
8697
10
Priyadarshi
,
A.
,
Khuder
,
S.A.
,
Schaub
,
E.A.
and
Priyadarshi
,
S.S.
(
2001
)
Environmental risk factors and Parkinson's disease: a meta analysis
.
Environ. Res.
86
,
122
127
11
Nussbaum
,
R.L.
and
Ellis
,
C.E.
(
2003
)
Alzheimer's disease and Parkinson's disease
.
NEJM
348
,
1356
1364
12
Ascherio
,
A.
and
Schwarzschild
,
M.A.
(
2016
)
The epidemiology of Parkinson's disease: risk factors and prevention
.
Lancet Neurol.
15
,
1257
1272
13
Bellou
,
V.
,
Belbasis
,
L.
,
Tzoulaki
,
I.
,
Evangelou
,
E.
and
Ioannidis
,
J.P.A.
(
2016
)
Environmental risk factors and Parkinson's disease: an umbrella review of meta-analyses
.
Parkinsonism Relat. Disord.
23
,
1
9
14
Uzuegbunam
,
B.C.
,
Librizzi
,
D.
and
Yousefi
,
B.H.
(
2020
)
PET radiopharmaceuticals for Alzheimer's disease and Parkinson's disease diagnosis, the current and future landscape
.
Molecules
25
,
977
15
Simola
,
N.
,
Morelli
,
M.
and
Carta
,
A.R.
(
2007
)
The 6-Hydroxydopamine model of Parkinson's disease
.
Neurotox. Res.
11
,
151
167
16
Meredith
,
G.E.
and
Rademacher
,
D.J.
(
2011
)
MPTP mouse models of Parkinson's disease:an update
.
J. Parkinson's Dis.
1
,
19
33
17
Nisticò
,
R.
,
Mehdawy
,
B.
,
Piccirilli
,
S.
and
Mercuri
,
N.
(
2011
)
Paraquat-and Rotenone-induced models of Parkinson's disease
.
Int. J. Immunopathol. Pharmacol.
24
,
313
322
18
Yuan
,
H.
,
Zhang
,
Z.-W.
,
Liang
,
L.-W.
,
Shen
,
Q.
,
Wang
,
X.-D.
,
Ren
,
S.-M.
et al (
2010
)
Treatment strategies for Parkinson's disease
.
Neurosci. Bull.
26
,
66
76
19
Konnova
,
E.A.
and
Swanberg
,
M.
(
2018
) Animal Models of Parkinson's Disease. In
Parkinson's Disease: Pathogenesis and Clinical Aspects
(
Stoker
,
T.B.
and
Greenland
,
J.C.
, eds),
Codon Publications Chapter 5
,
Brisbane (AU)
20
van Ham
,
T.J.
,
Thijssen
,
K.L.
,
Breitling
,
R.
,
Hofstra
,
R.M.W.
,
Plasterk
,
R.H.A.
and
Nollen
,
E.A.A.
(
2008
)
C. elegans model identifies genetic modifiers of α-synuclein inclusion formation during aging
.
PLoS Genet.
4
,
e1000027
21
Prachumwat
,
A.
and
Li
,
W.-H.
(
2007
)
Gene number expansion and contraction in vertebrate genomes with respect to invertebrate genomes
.
Genome Res.
18
,
221
232
22
Russell
,
W.M.S.
and
Burch
,
R.L.
(
1959
)
(As Reprinted 1992) The Principles of Humane Experimental Technique
,
Universities Federation for Animal Welfare
,
Wheathampstead, U.K
23
Betarbet
,
R.
,
Sherer
,
T.B.
and
Greenamyre
,
J.T.
(
2002
)
Animal models of Parkinson's disease
.
BioEssays
24
,
308
318
24
Duty
,
S.
and
Jenner
,
P.
(
2011
)
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
.
Br. J. Pharmacol.
164
,
1357
1391
25
Blandini
,
F.
and
Armentero
,
M.-T.
(
2012
)
Animal models of Parkinson's disease
.
FEBS J.
279
,
1156
1166
26
Elliott
,
S.A.
and
Sánchez Alvarado
,
A.
(
2013
)
The history and enduring contributions of planarians to the study of animal regeneration
.
Wiley Interdiscip. Rev. Dev. Biol.
2
,
301
326
27
Caronti
,
B.
,
Margotta
,
V.
,
Merante
,
A.
,
Pontieri
,
F.E.
and
Palladini
,
G.
(
1999
)
Treatment with 6-hydroxydopamine in planaria (Dugesia gonocephala s.l.): morphological and behavioral study
.
Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol.
123
,
201
207
28
Kitamura
,
Y.
,
Inden
,
M.
,
Sanada
,
H.
,
Takata
,
K.
,
Taniguchi
,
T.
,
Shimohama
,
S.
et al (
2003
)
Inhibitory effects of antiparkinsonian drugs and caspase inhibitors in a parkinsonian flatworm model
.
J. Pharmacol. Sci.
92
,
137
142
29
Nishimura
,
K.
,
Kitamura
,
Y.
,
Inoue
,
T.
,
Umesono
,
Y.
,
Sano
,
S.
,
Yoshimoto
,
K.
et al (
2007
)
Reconstruction of dopaminergic neural network and locomotion function in planarian regenerates
.
Dev. Neurobiol.
67
,
1059
1078
30
Buttarelli
,
F.R.
,
Pellicano
,
C.
and
Pontieri
,
F.E.
(
2008
)
Neuropharmacology and behavior in planarians: translations to mammals
.
Comp. Biochem. Physiol. C Toxicol. Pharmacol.
147
,
399
408
31
Nishimura
,
K.
,
Inoue
,
T.
,
Yoshimoto
,
K.
,
Taniguchi
,
T.
,
Kitamura
,
Y.
and
Agata
,
K.
(
2011
)
Regeneration of dopaminergic neurons after 6-hydroxydopamine-induced lesion in planarian brain
.
J. Neurochem.
119
,
1217
1231
32
Brenner
,
S.
(
1974
)
The genetics of Caenorhabditis elegans
.
Genetics
77
,
71
94
33
White
,
J.G.
,
Southgate
,
E.
,
Thomson
,
J.N.
and
Brenner
,
S.
(
1986
)
The structure of the nervous system of the nematode Caenorhabditis elegans
.
Philos. Trans. R. Soc. Lond. B Biol. Sci.
314
,
1
340
34
Sulston
,
J.
,
Dew
,
M.
and
Brenner
,
S.
(
1975
)
Dopaminergic neurons in the nematode Caenorhabditis elegans
.
J. Comp. Neurol.
163
,
215
226
35
Abdelhack
,
M.
(
2016
)
Dopaminergic neurons modulate locomotion in Caenorhabditis elegans
.
bioRxiv
1
14
36
Cooper
,
A.A.
,
Gitler
,
A.D.
,
Cashikar
,
A.
,
Haynes
,
C.M.
,
Hill
,
K.J.
,
Bhullar
,
B.
et al (
2006
)
Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
.
Science
313
,
324
328
37
Jadiya
,
P.
,
Mir
,
S.S.
and
Nazir
,
A.
(
2012
)
Effect of various classes of pesticides on expression of stress genes in transgenic C. elegans model of Parkinson's disease
.
CNS Neurol. Disord. Drug Targets
11
,
1001
1005
38
Tardiff
,
D.F.
,
Jui
,
N.T.
,
Khurana
,
V.
,
Tambe
,
M.A.
,
Thompson
,
M.L.
,
Chung
,
C.Y.
et al (
2013
)
Yeast reveal a “druggable” Rsp5/Nedd4 network that ameliorates α-synuclein toxicity in neurons
.
Science
342
,
979
983
39
Wang
,
S.
,
Zhang
,
S.
,
Liou
,
L.C.
,
Ren
,
Q.
,
Zhang
,
Z.
,
Caldwell
,
G.A.
et al (
2014
)
Phosphatidylethanolamine deficiency disrupts α-synuclein homeostasis in yeast and worm models of Parkinson disease
.
Proc. Natl Acad. Sci. U.S.A.
111
,
E3976
E3985
40
Hardenberg
,
M.C.
,
Sinnige
,
T.
,
Casford
,
S.
,
Dada
,
S.
,
Poudel
,
C.
,
Robinson
,
E.A.
et al (
2021
)
Observation of an α-synuclein liquid droplet state and its maturation into Lewy body-like assemblies
.
J. Mol. Cell Biol.
13
,
282
294
41
Surguchov
,
A.
(
2021
)
Invertebrate models untangle the mechanism of neurodegeneration in Parkinson's disease
.
Cells
10
,
407
42
Maulik
,
M.
,
Mitra
,
S.
,
Bult-Ito
,
A.
,
Taylor
,
B.E.
and
Vayndorf
,
E.M.
(
2017
)
Behavioral phenotyping and pathological indicators of Parkinson's disease in C. elegans models
.
Front. Genet.
8
,
77
43
Braungart
,
E.
,
Gerlach
,
M.
,
Riederer
,
P.
,
Baumeister
,
R.
and
Hoener
,
M.C.
(
2004
)
Caenorhabditis elegans MPP model of Parkinson's disease for high-throughput drug screenings
.
Neurodegener. Dis.
1
,
175
183
44
Masoudi
,
N.
,
Ibanez-Cruceyra
,
P.
,
Offenburger
,
S.L.
,
Holmes
,
A.
and
Gartner
,
A.
(
2014
)
Tetraspanin (TSP-17) protects dopaminergic neurons against 6-OHDA-induced neurodegeneration in C. elegans
.
PLoS Genet.
10
,
e1004767
45
Zhou
,
S.
,
Wang
,
Z.
and
Klaunig
,
J.E.
(
2013
)
Caenorhabditis elegans neuron degeneration and mitochondrial suppression caused by selected environmental chemicals
.
Int. J. Biochem. Mol. Biol.
4
,
191
200
https://e-century.us/files/ijbmb/4/4/ijbmb1309002.pdf
46
Sohrabi
,
S.
,
Mor
,
D.E.
,
Kaletsky
,
R.
,
Keyes
,
W.
and
Murphy
,
C.T.
(
2021
)
High-throughput behavioral screen in C. elegans reveals Parkinson's disease drug candidates
.
Commun. Biol.
4
,
203
47
Chase
,
R.
(
2002
)
Behavior and its Neural Control in Gastropod Molluscs
,
University Press
,
Oxford
,
314
pp
48
Tsyganov
,
V.V.
and
Sakharov
,
D.A.
(
2000
)
Locomotor rhythms in the pond snail Lymnaea stagnalis: site of origin and neurotransmitter requirements
.
Acta Biol. Hung.
51
,
189
195
49
Vehovszky
,
A.
,
Szabó
,
H.
,
Hiripi
,
L.
,
Elliott
,
C.J.H.
and
Hernádi
,
L.
(
2007
)
Behavioural and neural deficits induced by rotenone in the pond snail Lymnaea stagnalis. A possible model for Parkinson's disease in an invertebrate
.
Eur. J. Neurosci.
25
,
2123
2130
50
Tabassum
,
R.
and
Jeong
,
N.Y.
(
2019
)
Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases
.
Int. J. Med. Sci.
16
,
1386
1396
51
Billingsley
,
K.J.
,
Barbosa
,
I.A.
,
Bandres-Ciga
,
S.
,
Quinn
,
J.P.
,
Bubb
,
V.J.
,
Deshpande
,
C.
et al (
2019
)
Mitochondria function associated genes contribute to Parkinson's disease risk and later age at onset
.
NPJ Parkinsons Dis.
5
,
8
52
Ferreira
,
C.P.
,
Piazza
,
T.B.
,
Souza
,
P.
,
Lima
,
D.
,
Mattos
,
J.J.
,
Saldaña-Serrano
,
M.
et al (
2021
)
Integrated biomarker responses in oysters Crassostrea gasar as an approach for assessing aquatic pollution of a Brazilian estuary
.
Mar. Environ. Res.
165
,
105252
53
Regoli
,
F.
and
Giuliani
,
M.E.
(
2014
)
Oxidative pathways of chemical toxicity and oxidative stress biomarkers in marine organisms
.
Mar. Environ. Res.
93
,
106
117
54
Bertrand
,
L.
,
Monferrán
,
M.V.
,
Mouneyrac
,
C.
and
Amé
,
M.V.
(
2018
)
Native crustacean species as a bioindicator of freshwater ecosystem pollution: a multivariate and integrative study of multi-biomarker response in active river monitoring
.
Chemosphere
206
,
265
277
55
Iannone
,
M.
,
Ciriolo
,
M.R.
,
Rotilio
,
G.
and
Nisticò
,
G.
(
1991
)
Intra-nigral infusion of Cu-free superoxide dismutase prevents paraquat-induced behavioural stimulation and ECoG epileptogenic discharges in rats
.
Neuropharmacology
30
,
893
898
56
Lozada
,
M.
,
Romano
,
A.
and
Maldonado
,
H.
(
1990
)
Long-term habituation to a danger stimulus in the crab chasmagnathus granulatus
.
Physiol. Behav.
47
,
35
41
57
Bagheri
,
Z.M.
,
Donohue
,
C.G.
,
Partridge
,
J.C.
and
Hemmi
,
J.M.
(
2022
)
Behavioural and neural responses of crabs show evidence for selective attention in predator avoidance
.
Sci. Rep.
12
,
10022
58
Davison
,
A.
,
Wilson
,
B.D.
and
Belton
,
P.
(
1984
)
Deterioration of axonal membranes induced by phenolic pro-oxidants
.
Biochem. Pharmacol.
33
,
3887
3891
59
Wajsenzon
,
I.J.
,
de Carvalho
,
L.A.
,
Biancalana
,
A.
,
da Silva
,
W.A.
,
Dos Santos Mermelstein
,
C.
,
de Araujo
,
E.G.
et al (
2016
)
Culture of neural cells of the eyestalk of a mangrove crab is optimized on poly-L-ornithine substrate
.
Cytotechnology
68
,
2193
2206
60
Nässel
,
D.R.
and
Elekes
,
K.
(
1992
)
Aminergic neurons in the brain of blowflies and Drosophila: dopamine- and tyrosine hydroxylase-immunoreactive neurons and their relationship with putative histaminergic neurons
.
Cell Tissue Res.
267
,
147
167
61
Aryal
,
B.
and
Lee
,
Y.
(
2019
)
Disease model organism for Parkinson disease: Drosophila melanogaster
.
BMB Rep.
52
,
250
258
62
Polymeropoulos
,
M.H.
,
Lavedan
,
C.
,
Leroy
,
E.
,
Ide
,
S.E.
,
Dehejia
,
A.
,
Dutra
,
A.
et al (
1997
)
Mutation in the α-synuclein gene identified in families with Parkinson's disease
.
Science
276
,
2045
2047
63
Singleton
,
A.
,
Farrer
,
M.
,
Johnson
,
J.
,
Spitz
,
M.
,
Tan
,
E.K.
,
Tayebi
,
N.
et al (
2003
)
alpha-Synuclein locus triplication causes Parkinson's disease
.
Science
302
,
841
841
64
Zimprich
,
A.
,
Biskup
,
S.
,
Leitner
,
P.
,
Lichtner
,
P.
,
Farrer
,
M.
,
Lincoln
,
S.
et al (
2004
)
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology
.
Neuron
44
,
601
607
65
Zimprich
,
A.
,
Benet-Pagès
,
A.
,
Struhal
,
W.
,
Graf
,
E.
,
Eck
,
S.H.
,
Offman
,
M.N.
et al (
2011
)
A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease
.
Am. J. Hum. Genet.
89
,
168
175
66
Quadri
,
M.
,
Fang
,
M.
,
Picillo
,
M.
,
Olgiati
,
S.
,
Breedveld
,
G.J.
,
Graafland
,
J.
et al (
2013
)
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism
.
Hum. Mutat.
34
,
1208
1215
67
Blesa
,
J.
and
Przedborski
,
S.
(
2014
)
Parkinson's disease: animal models and dopaminergic cell vulnerability
.
Front. Neuroanat.
8
,
155
68
Madhi
,
I.
,
Kim
,
J.H.
,
Shin
,
J.E.
and
Kim
,
Y.
(
2021
)
Ginsenoside Re exhibits neuroprotective effects by inhibiting neuroinflammation via CAMK/MAPK/NF-κB signaling in microglia
.
Mol. Med. Rep.
24
,
698
69
Yang
,
X.
,
Chu
,
S.F.
,
Wang
,
Z.Z.
,
Li
,
F.F.
,
Yuan
,
Y.H.
and
Chen
,
N.H.
(
2021
)
Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington's disease via suppressing MAPKs and NF-κB pathways in the striatum
.
Acta Pharmacol. Sin.
42
,
1409
1421
70
Liu
,
Y.
,
Yu
,
S.
,
Xing
,
X.
,
Qiao
,
J.
,
Yin
,
Y.
,
Wang
,
J.
et al (
2021
)
Ginsenoside Rh2 stimulates the production of mitochondrial reactive oxygen species and induces apoptosis of cervical cancer cells by inhibiting mitochondrial electron transfer chain complex
.
Mol. Med. Rep.
24
,
873
71
Qiao
,
J.
,
Zhao
,
Y.
,
Liu
,
Y.
,
Zhang
,
S.
,
Zhao
,
W.
,
Liu
,
S.
et al (
2022
)
Neuroprotective effect of Ginsenoside Re against neurotoxin-induced Parkinson's disease models via induction of Nrf2
.
Mol. Med. Rep.
25
,
215
72
Maitra
,
U.
,
Harding
,
T.
,
Liang
,
Q.
and
Ciesla
,
L.
(
2021
)
Gardenina confers neuroprotection against environmental toxin in a Drosophila model of Parkinson's disease
.
Commun. Biol.
4
,
162
73
Delsuc
,
F.
,
Brinkmann
,
H.
,
Chourrout
,
D.
and
Philippe
,
H.
(
2006
)
Tunicates and not cephalochordates are the closest living relatives of vertebrates
.
Nature
439
,
965
968
74
Zega
,
G.
,
Pennati
,
R.
,
Groppelli
,
S.
,
Sotgia
,
C.
and
De Bernardi
,
F.
(
2005
)
Dopamine and serotonin modulate the onset of metamorphosis in the ascidian Phallusia mammillata
.
Dev. Biol.
282
,
246
256
75
Moret
,
F.
,
Christiaen
,
L.
,
Deyts
,
C.
,
Blin
,
M.
,
Joly
,
J.S.
and
Vernier
,
P.
(
2005
)
The dopamine-synthesizing cells in the swimming larva of the tunicate Ciona intestinalis are located only in the hypothalamus-related domain of the sensory vesicle
.
Eur. J. Neurosci.
21
,
3043
3055
76
Zega
,
G.
,
Candiani
,
S.
,
Groppelli
,
S.
,
De Bernardi
,
F.
and
Pennati
,
R.
(
2010
)
Neurotoxic effect of the herbicide paraquat on ascidian larvae
.
Environ. Toxicol. Pharmacol.
29
,
24
31
77
Chen
,
J.
,
Su
,
Y.
,
Lin
,
F.
,
Iqbal
,
M.
,
Mehmood
,
K.
,
Zhang
,
H.
et al (
2021
)
Effect of paraquat on cytotoxicity involved in oxidative stress and inflammatory reaction: a review of mechanisms and ecological implications
.
Ecotoxicol. Environ. Saf.
224
,
112711
78
De Souza
,
J.F.
,
Mello
,
A.A.
,
Portal
,
T.M.
,
Nunes-da-Fonseca
,
R.
and
De Barros
,
C.M.
(
2021
)
Novel insights about the ascidian dopamine system: pharmacology and phylogenetics of catecholaminergic receptors on the Phallusia nigra immune cells
.
Fish Shellfish Immunol.
109
,
41
50
79
Medina
,
B.N.S.P.
,
Santos de Abreu
,
I.
,
Cavalcante
,
L.A.
,
Silva
,
W.A.B.
,
da Fonseca
,
R.N.
,
Allodi
,
S.
et al (
2015
)
3-Acetylpyridine induced degeneration in the adult ascidian neural complex: reactive and regenerative changes in glia and blood cells
.
Dev. Neurobiol.
75
,
877
893
80
De Abreu
,
I.S.
,
Wajsenzon
,
I.J.R.
,
Dias
,
J.C.
,
Allodi
,
S.
and
De Barros
,
C.M.
(
2022
)
Central nervous system regeneration in ascidians: cell migration and differentiation
.
Cell Tissue Res.
390
,
335
354
81
Akinade
,
T.C.
,
Babatunde
,
O.O.
,
Adedara
,
A.O.
,
Adeyemi
,
O.E.
,
Otenaike
,
T.A.
,
Ashaolu
,
O.P.
et al (
2022
)
Protective capacity of carotenoid trans-astaxanthin in rotenone-induced toxicity in Drosophila melanogaster
.
Sci. Rep.
12
,
4594
82
Aggarwal
,
A.
,
Reichert
,
H.
and
VijayRaghavan
,
K.
(
2019
)
A locomotor assay reveals deficits in heterozygous Parkinson's disease model and proprioceptive mutants in adult Drosophila
.
Proc. Natl Acad. Sci. U.S.A.
116
,
24830
24839
83
Gentile
,
L.
,
Cebrià
,
F.
and
Bartscherer
,
K.
(
2011
)
The planarian flatworm: an in vivo model for stem cell biology and nervous system regeneration
.
Dis. Model. Mech.
4
,
12
19
84
Kitamura
,
Y.
,
Kakimura
,
J.I.
and
Taniguchi
,
T.
(
1998
)
Protective effect of talipexole on MPTP-treated planarian, a unique parkinsonian worm model
.
Jpn. J. Pharmacol.
78
,
23
29
85
Hagstrom
,
D.
,
Cochet-Escartin
,
O.
and
Collins
,
E.M.S.
(
2016
)
Planarian brain regeneration as a model system for developmental neurotoxicology
.
Regeneration
3
,
65
77
86
Chege
,
P.M.
and
McColl
,
G.
(
2014
)
Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's disease
.
Front. Aging Neurosci.
6
,
89
87
Dung
,
V.M.
and
Thao
,
D.T.P.
(
2018
)
Parkinson's disease model
. In: Yamaguchi, M. (ed.)
Drosophila Models for Human Diseases
.
Adv. Exp. Med. Biol.
Vol.
1076
,
Springer
,
Singapore
.
88
Tascedda
,
F.
,
Malagoli
,
D.
,
Accorsi
,
A.
,
Rigillo
,
G.
,
Blom
,
J.M.
and
Ottaviani
,
E.
(
2015
)
Molluscs as models for translational medicine
.
Med. Sci. Monit. Basic Res.
21
,
96
99
89
Allodi
,
S.
and
Taffarel
,
M.
(
1999
)
Electron microscopy of glial cells of the central nervous system in the crab ucides cordatus
.
Braz. J. Med. Biol. Res.
32
,
327
331
90
da Silva
,
S.F.
,
Taffarel
,
M.
and
Allodi
,
S.
(
2001
)
Crustacean visual system: an investigation on glial cells and their relation to extracellular matrix
.
Biol. Cell
93
,
293
299
91
Eliss
,
D.E.
(
1968
)
Transition from water to land in decapod crustaceans
.
Am. Zool.
8
,
355
392
92
Watson-Zink
,
V.M.
(
2021
)
Making the grade: physiological adaptations to terrestrial environments in decapod crabs
.
Arthropod Struct. Dev.
64
,
101089
93
Steenkamp
,
V.E.
,
Du Preez
,
H.H.
,
Schoonbee
,
H.J.
,
Wiid
,
A.J.B.
and
Bester
,
M.M.
(
1993
)
Bioaccumulation of iron in the freshwater crab (Potamonautes warreni) from three industrial, mine and sewage polluted freshwater ecosystems in the Transvaal
.
Water SA
19
,
281
290
94
Blanco
,
J.
,
Pandey
,
R.
,
Wasser
,
M.
and
Udolph
,
G.
(
2011
)
Orthodenticle is necessary for survival of a cluster of clonally related dopaminergic neurons in the Drosophila larval and adult brain
.
Neural Dev.
6
,
1
14
95
Sasakura
,
Y.
,
Mita
,
K.
,
Ogura
,
Y.
and
Horie
,
T.
(
2012
)
Ascidians as excellent chordate models for studying the development of the nervous system during embryogenesis and metamorphosis
.
Dev. Growth Differ.
54
,
420
437
96
Dahlberg
,
C.
,
Auger
,
H.
,
Dupont
,
S.
,
Sasakura
,
Y.
,
Thorndyke
,
M.
and
Joly
,
J.S.
(
2009
)
Refining the Ciona intestinalis model of central nervous system regeneration
.
PLoS ONE
4
,
e4458
97
Barron
,
A.B.
,
Søvik
,
E.
and
Cornish
,
J.L.
(
2010
)
The roles of dopamine and related compounds in reward-seeking behavior across animal phyla
.
Front. Behav. Neurosci.
4
,
163
98
Imperadore
,
P.
and
Fiorito
,
G.
(
2018
)
Cephalopod tissue regeneration: consolidating over a century of knowledge
.
Front. Physiol.
9
,
593
This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY-NC-ND).